BTIG analysts continue to expect growth from Dexcom (Nasdaq:DXCM) after meeting with the company's senior investor relations (IR) officials.
Dexcom will stop producing G6 CGM sensors July 1, 2026, urging patients to switch to the smaller, more accurate G7 model.
Dexcom stock plunged to a four-month low Monday after the Food and Drug Administration issued the diabetes devices maker a warning letter tied to inspections of two facilities in the U.S. The warning ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Dexcom, Inc. DXCM announced that its Dexcom G6 CGM System would be available for all eligible patients with type 1 and type 2 diabetes in the Canadian province, Manitoba, irrespective of their age. It ...
DexCom (NASDAQ:DXCM) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ratings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results